Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 128 / Thursday, July 8, 2021 / Rules and Regulations requestor with an accessible format that may include Rich Text Format RTF or text format txt, a thumb drive, an MP3
file, braille, large print, audiotape, or compact disc, or other accessible format.
Electronic Access to This Document:
The official version of this document is the document published in the Federal Register. You may access the official edition of the Federal Register and the Code of Federal Regulations at www.govinfo.gov. At this site, you can view this document, as well as all other documents of this Department published in the Federal Register, in text or Portable Document Format PDF. To use PDF, you must have Adobe Acrobat Reader, which is available free at the site.
You may also access documents of the Department published in the Federal Register by using the article search feature at www.federalregister.gov.
Specifically, through the advanced search feature at this site, you can limit your search to documents published by the Department.
Michelle Asha Cooper, Acting Assistant Secretary for Postsecondary Education.
FR Doc. 202114359 Filed 7721; 8:45 am BILLING CODE 400001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
45 CFR Part 155
CMS9914CN
RIN 0938AU18

Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards;
Correction Centers for Medicare &
Medicaid Services CMS, Department of Health & Human Services HHS.
ACTION: Final rule; correction.
AGENCY:

This document corrects technical errors in the final rule that appeared in the May 5, 2021, Federal Register entitled, Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards.

lotter on DSK11XQN23PROD with RULES1

SUMMARY:

This correction is effective on July 6, 2021.
FOR FURTHER INFORMATION CONTACT: Jeff Wu, 301 4924305, Rogelyn McLean, 301 4924229, Grace Bristol, 410
7868437, Kiahana Brooks, 301 492
DATES:

VerDate Sep<11>2014

15:48 Jul 07, 2021

Jkt 253001

5229, or Sara Rosta, 301 4924223 for general information.
SUPPLEMENTARY INFORMATION:
I. Background In FR Doc. 202109102 of May 5, 2021, the Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards final rule 86 FR 24140, there were technical errors that are identified and corrected in the regulation text of this correcting document. The correction is effective on July 6, 2021, as this is the date that the relevant regulations contained in the Patient Protection and Affordable Care Act;
HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards final rule take effect.
II. Summary of Error in the Regulation Text On page 24289 of the Patient Protection and Affordable Care Act;
HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards final rule, we made technical errors in amendatory instructions 27b and d for 155.221. In these amendatory instructions, we inadvertently noted that we were: 1
Redesignating paragraphs c through h as paragraphs d through i, respectively; and 2 amending newly redesignated paragraphs g introductory text, g6 and 7, and h by removing the reference to paragraph e and adding in its place a reference to paragraph f. These amendatory instructions were duplicative of amendatory instructions 6a and c of the final rule that appeared in the January 19, 2021 Federal Register, entitled Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022; Updates to State Innovation Waiver Section 1332
Waiver Implementing Regulations 86
FR 6176. Therefore, in addition to amendatory instruction 27a, we should have only included the addition of paragraph c for changes to 155.221 in the Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards final rule. Accordingly, we are revising amendatory instruction 27b to accurately reflect the addition of paragraph c and removing amendatory instructions 27c and d.
III. Waiver of Proposed Rulemaking and Delay in Effective Date Under 5 U.S.C. 553b of the Administrative Procedure Act the
PO 00000

Frm 00011

Fmt 4700

Sfmt 4700

36071

APA, the agency is required to publish a notice of the proposed rule in the Federal Register before the provisions of a rule take effect. In addition, section 553d of the APA mandates a 30-day delay in effective date after issuance or publication of a rule. Sections 553bB
and 553d3 of the APA provide for exceptions from the APA notice and comment, and delay in effective date requirements. Section 553bB of the APA authorizes an agency to dispense with normal notice and comment rulemaking procedures for good cause if the agency makes a finding that the notice and comment process is impracticable, unnecessary, or contrary to the public interest, and includes a statement of the finding and the reasons for it in the rule. In addition, section 553d3 of the APA allows the agency to waive the 30-day delay in effective date where such delay is contrary to the public interest and the agency includes in the rule a statement of the finding and the reasons for it.
This document merely corrects technical errors in the Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards final rule that was published on May 5, 2021 for amendments that become effective on July 6, 2021. The corrections do not make substantive changes to the policies or standards set forth in the final rule. Therefore, we believe that undertaking further notice and comment procedures to incorporate these corrections and delay the effective date for these changes is unnecessary. In addition, we believe that it is important for the public to have the correct information as soon as possible and believe it is contrary to the public interest to delay when they become effective. For these reasons, we believe there is good cause to waive the requirements for notice and comment and delay in effective date for this correction document.
Correction In FR 202109102, appearing on page 24140 in the Federal Register of Wednesday, May 5, 2021, the following correction is made:
155.221

Corrected
On page 24289, in the first column, the text of instruction 27 for 155.221
is corrected to read as follows:
27. Section 155.221 is amended by revising paragraphs b1, 3, and 4

E:FRFM08JYR1.SGM

08JYR1